In order to investigate the mechanisms involved in the processing of infectious bronchitis virus polyproteins, several candidate regions of the genome have been cloned and expressed in vitro. During these studies it was observed that the translation product encoded by one of these clones (pKT205) was poorly expressed. Biochemical and genetic analyses revealed that the basis for the poor expression was a post-translational event involving ubiquitination of the protein and degradation by an ATP-dependent system operating in the reticulocyte lysate used for the in vitro expression. Two independently acting regions which conferred instability were identified, one of which mapped to the predicted 3C protease domain, contained within the 5' end of the clone, while the other, more C-terminal region, was effective in conferring instability upon a heterologous protein to which it had been transferred. These regions may influence the stability of the authentic viral protein(s) in vivo and hence allow for the control of their expression and/or function at the level of proteolysis by cellular protease(s).
Introduction
Coronaviruses employ several mechanisms in order to co-ordinate expression of the linear arrangement of genes from their large positive-sense ssRNA genomes. In the case of avian infectious bronchitis virus (IBV), the mechanisms so far identified are: (i) subgenomic messenger RNA production; (ii) ribosomal frameshifting; (iii) internal initiation of translation; and (iv) polyprotein expression and processing (Brown & Brierley, 1995) . This last feature is shared with many other positivestrand viruses such as picornaviruses and flaviviruses, but has been studied much less extensively in coronaviruses.
Coronavirus replication must initiate, upon entry of the genomic RNA into permissive cells, with translation of the input RNA to produce the viral RNA-dependent RNA polymerase. This activity copies the genomic RNA into a negative-sense template which is then transcribed, producing a nested set of 3' co-terminal transcripts from which further viral protein synthesis proceeds (reviewed * Author for correspondence. Fax +44 1223 336926. e-mail tdkb@mole.bio.cam.ac.uk in Spaan et al., 1988; Lai, 1990) . In the case of IBV the transcripts include the full-length genomic RNA, mRNA1 of 27-6 kb and five subgenomic RNAs (Stern & Kennedy, 1980 ) designated mRNAs 2-6 in descending order of size (Cavanagh et al., 1990) . Each transcript in the series specifies one of the genes in the linear genome arrangement by virtue of the portion of genomic sequence at its 5' terminus that is not present in the next smallest transcript (Stern & Sefton, 1984) . Most of the coding potential of the IBV genome (approximately 70%) is contained within two large overlapping open reading frames, ORFs la and lb, present in the' unique' region, comprising gene 1, located at the 5' end of mRNA1 . The remaining (eight) ORFs, including those of all structural proteins identified to date, are encoded within the remaining 3' end of the genome and are expressed from the subgenomic mRNAs. It would seem that nonstructural proteins, including the polymerase function(s), predominate in gene 1. Although a number of replication-associated activities have been predicted to be encoded by mRNA1 (Gorbalenya et al., 1989) , little is known concerning the identity or function of the ORF la and lb products.
The region of overlap between ORFs la and lb is only 42 nucleotides, with ORF lb occupying the -1 frame with respect to ORF la. Data have been reported demonstrating ribosomal frameshifting between ORFs la and lb (Brierley et al., 1987 (Brierley et al., , 1989 which allows readthrough of the la stop codon and therefore expression of lb (which does not have its own subgenomic mRNA) as a fusion product la/lb. Thus, translation of gene 1 would result potentially in a stopped product (from ORF la) of 441 kDa and a read-through product (from la/lb) of 741 kDa. Similar arrangements have been demonstrated for other coronaviruses including mouse hepatitis virus (MHV; Lee et al., 1991) and human coronavirus (HCV) strain 229E (Herold et al., 1993) . These large precursors undergo post-or co-translational processing in order to generate the mature non-structural proteins associated with viral replication. Attempts to identify and relate precursors and processed products in IBVinfected cells using monospecific antisera met with some success (Brierley et al., 1990) . A number of viral polypeptides were detected, although the low levels of mRNAl-encoded polypeptides present in infected cells and an incomplete range of reactive antisera have made further analyses difficult. In vivo processing data have also been reported for MHV (Denison et al., 1992) , where evidence of multiple proteolytic events was presented. These technical difficulties and the complexity of the events involved make the development of in vitro systems desirable. Two potential protease domains have been identified within the IBV ORF la sequence (Gorbalenya et al., 1989) , one of which (3CLP) shows high similarity to the picornavirus 3C-like proteases and is common to all coronaviruses so far analysed. Using a vaccinia virus-T7 expression system, this domain has recently been shown to exhibit authentic processing activity when appropriate regions ofORF 1 are expressed (Liu et al., 1994) . Until recently, the only in vitro processing activity reported had been for the MHV papain-like protease (PLP1), located towards the 5' end of the genome and apparently absent from IBV. In the case of MHV, a 28 kDa polypeptide (p28) synthesized in virus-infected cells (Denison & Perlman, 1987) has been shown to be derived from the N terminus of a larger precursor when expressed from the 5' end of ORF la in vitro (Denison & Perlman, 1986; Soe et al., 1987) . This cleavage is mediated by PLP1 (Baker et al., 1989 (Baker et al., , 1993 . Two recent reports have now described in vitro processing activities for cloned 3C-like proteases of both MHV (Lu et al., 1995) and HCV (Ziebuhr et al., 1995) .
Our present studies concern the characterization of the mechanism(s) involved in IBV polyprotein processing by examination of the in vitro expression of gene 1 from cloned viral sequences corresponding to ORFs la and lb. Given that the sizes of ORFs la and lb represent severe challenges to expression by the in vitro transcription and translation systems currently available, and to simplify interpretation, we sought initially to express several smaller overlapping clones covering the la/lb region using bacteriophage T7 RNA polymerase and rabbit reticulocyte lysate. Here we report data on the expression of one of these clones which suggest that a region ofORF 1 a encoding the 3C-like protease domain is a target for the ubiquitin-mediated ATP-dependent degradation system present in the lysate. This finding is discussed in the light of recent reports in which a number of other virus groups appear to use this cellular system to control protein expression/function and particularly in regard to an emerging pattern of metabolic instability amongst 3Clike viral proteases.
Methods
Plasmids. The IBV expression plasmids described in this report were constructed from eDNA clones generated originally by Boursnell et al. (1987) . The relevant eDNA fragments were purified from their vector backgrounds and cloned into a T7 transcription vector pKT0/NS1 (Liu et al., 1994) . This vector provides an efficient eukaryotic translation initiation module to allow expression of DNA sequences introduced at appropriate in-frame downstream restriction sites. A StuI-PstI fragment (clone 205), comprising IBV sequence information from nucleotide (nt) position 8693 to approximately 10930 was introduced in-frame into pKT0/NS1, at the EcoRV and PstI restriction sites, to yield pKT205. A similarly-sized NsiI-PstI fragment (clone BP5) corresponding to the IBV sequence from nt 10752 to approximately 12600 was introduced in-frame at the PstI site of pKT0/NS1 to produce pKTBP5. Construction of these plasmids has been detailed elsewhere (Liu et al., 1994) .
A frameshift mutant of the 205 sequence (pKT205AC N°°) was obtained by digestion of pKT205 with NcoI followed by end-repair and religation. The introduction of the additional 4 bp (at the unique NcoI site at nt 10118) results in a frameshift of translation such that a stop codon is encountered 35 bases downstream. A larger C-terminal deletion plasmid was created by excision of a NslI (nt 9370)-PstI (polylinker) fragment from the parental pKT205 plasmid to yield pKT205AC r~i. The N-terminal deletion construct pKT205AN Pvu was constructed by recloning the 205 sequence between the PvulI site (nt 9911) and the PstI site (polylinker) into EcoRV/PstI-digested pKT0/NS1 vector.
Plasmids pKT1 ÷ and pKT1/205 were obtained as follows: a DNA fragment corresponding to influenza virus segment 2, encoding PB1, was excised from pAPR206 (Young et al., 1983) by digestion with EcoRI, end-repaired and introduced into PvulI-digested pKT0 (Liu et al., 1994) to produce pKT1 ÷. This plasmid was digested with EcoRV (nt 2156) and AvaI (polylinker) to allow insertion of a XmnI (nt lO184)-AvaI (polylinker) fragment from pKT205 encoding the Cterminal end of the 205 protein. Oligonucleotide-directed mutagenesis was employed to restore the EcoRV site and the reading frame at the PB~-205 junction such that the two ORFs were in the same reading frame and translationally fused. A deletion of the C-terminal half of the PB 1 sequence within pKT1/205 was performed to create pKT1 AC/205. This was achieved by the mutagenic insertion of an in-frame EcoRV site 1 kb upstream of the existing EcoRV site, followed by excision of the intervening sequence by EeoRV digestion and religation of the plasmid. All cloning steps were confirmed by restriction enzyme digestion and dideoxynucleotide sequencing of cloning junctions. The control construct (for energy-dependent degradation), expressing a human papillomavirus type 16 (HPV-16) E6~yclin chimeric protein, was kindly provided by T. Crook (Raine Institute, King's College, University of London, London, UK).
Mutagenesis. The pKT0/NS1 expression vector carries the packaging signals for the filamentous bacteriophage fl (Dotto et al., 1981) enabling the rescue of ssDNA following superinfection of bacterial cells (bearing the plasmid) with phage R408 (Russel et al., 1986) . Oligonucleotide-directed mutagenesis (Kunkel, 1985) was carried out as described by Brierley et al. (1989) .
In vitro transcription and translation. Plasmid DNA was linearized at an appropriate restriction site downstream of the IBV sequence (unless stated otherwise) prior to transcription by T7 RNA polymerase as described (Brierley et al., 1987) . RNA was purified by spun-column chromatography, concentrated by ethanol precipitation and translated in an mRNA-dependent rabbit reticulocyte lysate (Promega) containing [35S]methionine (0"75mCi/ml). Alternatively, a coupled transcription-translation system was used (Craig et al., 1992) . In this protocol, MgC12 and NTPs were added to the lysate at approximately 5 mM and 1 raM, respectively, and reactions initiated by the addition of undigested plasmid DNA and T7 RNA polymerase. Reactions were terminated (typically after 1 h) by incubation with 1 x translation stop buffer (2 mM-L-methionine, 500 ~tg/ml cycloheximide, 50 mg/ml DNase 1 and 50 mg/ml RNase A) for 15 rain at 30 °C. Expression of the E6~zyclin protein was achieved using the SP6-qualified wheatgerm transcription-translation system from Promega. Polypeptide products were separated on 15 % polyacrylamid~SDS gels (Hames, 1981) and visualized by autoradiography (unless stated otherwise).
Protease assays. Assays (10 ~tl) were performed typically using 1 ~1 of a completed translation reaction, 1 lal of 10 × translation stop buffer and 5-8 lal of reticulocyte lysate (unless stated otherwise). Incubation was carried out for 1 h at 30 °C, or up to 3 h where indicated. The multicatalytic protease inhibitor MG132 was a generous gift from F. Baleux and R.T. Hay (School of Biological and Medical Sciences, University of St Andrews, St Andrews, UK) and was used at 50 laM. When utilized, adenosine-5'-O-(3-thiotriphosphate) (7-S-ATP; 4 mM final concentration) was added to the lysate prior to addition to target translates. Reactions were terminated by boiling in SDS sample buffer prior to electrophoresis.
Preparation of labelled ubiquitin and ubiquitin complexes.
A modified version of ubiquitin was kindly supplied by A. Klotzbiicher (Imperial Cancer Research Fund, South Mimms, Hertfordshire, UK). This protein has been engineered so as to contain an N-ternainal peptide sequence that acts as a substrate for phosphorylation by the catalytic subunit of protein kinase A (Boehringer Mannheim). Phosphorylation using [?-~ZP]ATP as a phosphate donor was carried out at 37 °C for 15 min following the manufacturer's guidelines. Free label was removed by gel filtration. Approximately 1 gg of labelled ubiquitin was incubated alone or in the presence of 5 gl of reticulocyte lysate for 15 min at room temperature to allow incorporation into multiubiquitin complexes with endogenous lysate proteins. Alternatively, labelling was carried out after complex formation using lysate that had been incubated alone or in the presence of the engineered ubiquitin.
Ubiquitin depletion ofreticulocyte lysate. Aliquots of lysate (100 lal) were diluted 25-fold with buffer (10mM-Tris-HC1 pH 7.4, 1 mM-MgCI~) and concentrated back to the original volume using a centricon 10 filtration unit (Amicon). Lysates were resupplemented with ATP (to 1 mM) and creatine phosphate (to 10 mM) and used in a ubiquitination assay as follows: reactions were carried out as described for the protease assay above except that depleted lysate, supplemented or unsupplemented with purified bovine ubiquitin (5 gg; Sigma), was used in place of untreated lysate. Incubation was restricted to 15 min (at room temperature) to prevent significant degradation of the ubiquitintarget complexes.
Results

Observations that reveal two potential degradation signals within the 205 protein
The 205 clone was chosen for expression analysis as it encodes the predicted 3C-like protease domain as well as several potential cleavage sites (Gorbalenya et al., 1989) and was expected therefore to provide the basis for in vitro processing studies. In vitro expression of the pKT205 plasmid was predicted to yield a 75 kDa primary translation product which, as shown in Fig. 1 (a) lane 2, could be detected although in comparatively low abundance. The predominant products of translation were truncated forms, most of which probably arose from premature termination events since 3' truncation of the RNA did not affect their relative mobilities (i.e. they share common N-termini; see Fig. 2 a, lanes 3, 4 and 5). Attempts to investigate the possibility that autoproteolysis of the 205 protein was occurring were hampered by the complexity of the translation pattern (released 3C is expected to migrate at approximately 35 kDa); synthesis in the presence of a range of water soluble protease inhibitors did not reveal significant differences in the pattern obtained (data not shown). Another feature of the translation pattern for the 205 clone was the incorporation of significant amounts of radiolabel into heterogeneous high molecular mass products which formed a smear extending from around 50 kDa to the top of the separating gel, where a proportion appeared unable to penetrate. This pattern was unaffected by the RNase treatment of sample preparation. The appearance of high molecular mass species contrasted strongly with the pattern of protein synthesis from other regions of gene 1, as shown by the example in Fig. 1 (a) , lane 1. This pattern was produced from the expression of the BP5 sequence, which lies adjacent to and downstream from the 205 region (though overlapping by some 200 bases) in the IBV genome. Two translation products of 60 and 70 kDa were obtained which were of the sizes expected to result from translation termination and frameshifting events at the la/lb boundary, contained within the 3' end of the BP5 clone. There were several background bands but no evidence of significant amounts of high molecular mass heterogeneous material.
A time-course analysis of the expression of the 205 protein was performed ( Fig. 1 b) to examine whether the poor level of full-length 205 protein resulted from poor expression per se or from instability. Full-length product was detectable by 30 min and increased for a further 30 min before declining, a pattern also exhibited by some of the shorter products. No accumulation of shorter products was observed to suggest that processing was occurring. Throughout this latter period, the high molecular mass material was seen to accumulate at the top of the gel, an observation consistent with the conversion of free nascent protein into these other forms. Accumulation of the high molecular mass material appeared dependent upon completion, or near completion, of the full-length translation product. The behaviour of the 205 protein is suggestive of the multiubiquitination that normally occurs prior to degradation of such targeted proteins by an energy-dependent 26S cellular protease complex (Hershko et al., 1984) .
Since the 205 clone encodes the predicted 3C-tike protease domain of IBV, this observation suggested a correlation with the observed low in vitro stability of the encephalomyocarditis virus (EMCV) 3C protease, which has been attributed to energy-dependent proteolysis (Oberst et al., 1993) . We tested the importance of the C terminus in determining the behaviour of the 205 protein by translation of a series of Y-terminally truncated RNA transcripts obtained by run-off transcription of appropriately linearized pKT205 plasmid. As revealed in Fig. 2(a) , primary translation products of the expected sizes were obtained from the corresponding truncated RNAs and there was no evidence for autocatalytic processing, as had been anticipated. This strongly implicates the C terminus of the full-length 205 protein (beyond the HincII site) in determining its fate. We had considered the possibility that the reduced expression of the 205 protein may have arisen as a result of inefficient initiation of translation, perhaps caused by an interaction between the initiation start site and the Y end of the RNA produced from the full-length 205 construct. However, when we expressed a variant 205 plasmid, pKT205AC N°° (Fig. 3a, lane 1) , in which a frameshift mutation had been introduced at the unique NcoI site (position 10118, see Methods), translation was relatively efficient, producing a translation product of the expected size. In pKT205AC ~c°, the C terminus of 205 is not expressed, since the introduced frameshift mutation brings a nonsense codon into register some 11 amino acids downstream of the introduced frameshift. Yet an almost identical RNA sequence is retained, strongly supporting the notion that the poor levels of 205 protein were due to a post-initiation event. If these levels are caused by degradation of ubiquitinated forms, the data would suggest the involvement of the C terminus in targeting. However, the C terminus lies beyond the predicted 3C protease domain (which resides at the N terminus of the 205 protein) and there was still evidence consistent with some ubiquitination of the NcoI and HincII products (Fig. 2a, lanes 4 and 5; Fig. 3a, lanes 1  and 3) suggesting that a second ubiquitination signal could also be present. As the extent of production of the high molecular mass material was considerably reduced in these translations, it was considered possible that the putative ubiquitination at this second site could be limited by the availability of the necessary components in the lysate. This was tested by incubating the HincIItruncated translation product with increasing amounts of unprogrammed reticulocyte lysate under conditions where further translation was prevented. As shown in Fig. 2(b) , the protein was seen to convert progressively into high molecular mass forms, becoming trapped at the top of the gel. This could not be demonstrated for a metabolically stable control protein (influenza virus PB x ; see below) indicating the specificity of the process. Also apparent was the loss of a significant amount of the total radiolabelled material in the presence of the higher amounts of added lysate, suggesting that degradation of some of the protein had occurred. Degradation was confirmed by analysis of TCA-precipitable radiolabelled product over a 2 h period (data not shown).
The possibility that two degradation signals (degrons) exist within the 205 sequence was confirmed by the experiments shown in Fig. 3 (a) , which were performed to demonstrate the ATP dependence of the instability of the 205 proteins. The target proteins produced from plasmids pKT205 (BstXI-restricted), pKT205AC ~c°, pKT205AC ~s~ and pKT205AN Pvu were incubated in the presence or absence of excess lysate containing y-S-ATP. In the presence of this ATP analogue, ubiquitinated proteins accumulate, since 7-S-ATP can substitute for ATP in the ubiquitination reaction but not the consequent degradation reaction (Scheffner et al., 1992) . As seen by comparing lanes 1 and 2 of Fig. 3(a) , this treatment resulted in the conversion of the pKT205AC N°° product along with most of the incomplete translation products to high molecular mass forms. This was accompanied by stabilization of the high molecular mass material retained at the top of the gel, suggesting that the degradation (as seen in Fig. 2b ) was ATPdependent. Some laddering of the pKT205AC N°° product was evident, which would be consistent with ubiquitination prior to degradation. The BstXI protein, which also exhibited a defined (RNase-resistant) ladder of protein species (Fig. 3 a, lane 3) , was also significantly diminished by the addition of excess lysate (lane 4), as was the NsiI protein (compare lanes 5 and 6). An increase in the ubiquitinated forms at the top of the gel could also be detected in each case. The N-terminal deletion protein (AN Pvu, lane 7) which bears the original C-terminal signal (beyond the HincII site) clearly demonstrated laddering, the spacing of which was consistent with the sequential addition of ubiquitin moieties (of approximately 8 kDa), as expected for a classical ubiquitin ladder (Hough & Rechsteiner, 1986) . This pattern was observed when the protein was expressed using separate transcription and translation reactions, so did not represent an artefact of the coupled system. The ladder was converted to high molecular mass products by the addition of excess lysate (lane 8). Similar results were observed when extracts made from Vero cells (a cell type permissive for viral infection) were used (data not shown). It is not clear why the processes of degradation fail to finish without the addition of excess lysate (all incubations were carried out under conditions that prevent further protein synthesis). One possibility is that of factor limitation within the lysate (we have noted batch variation in the degree of activity), although the addition of purified bovine or yeast ubiquitin did not increase the rate or extent of the reaction(s) (data not shown). An alternative explanation is that only a proportion of the necessary factors potentially involved are free to operate due to regulatory mechanisms. The primary structures of the proteins used are summarized in Fig. 3(b) . The behaviour of the pKT205AC ~si-and pKT205ANVVU-derived proteins, which do not overlap, confirms the independent nature of the destabilizing regions. Therefore, two degrons are proposed. The first lies between the N terminus of the 205 protein and the NsiI site and would therefore reside within the N-terminal portion of the predicted 3C domain; the second is bounded by the PvulI site and the C terminus of the 205 protein and would appear to lie beyond the HinclI site, according to the results shown in Fig. 2(a) .
Evidence for the involvement of ubiquitin in the modification of target proteins
The laddering observed during translation of the 205 proteins and their conversion, along with the corresponding 'free' products, to high molecular mass modified forms by the reticulocyte lysate was very suggestive of the multiubiquitination that occurs prior to degradation by the multicatalytic protease. Further evidence for this was provided by the following observations: Fig. 4(a) shows the behaviour of labelled ubiquitin when incubated with reticulocyte lysate. In the presence of lysate (15 min incubation) a proportion of the ubiquitin was seen to become incorporated into high molecular mass material at the top of the gel, presumably as the result of involvement in the ubiquitination of endogenous lysate proteins (compare left and right lanes in each panel). This could be observed whether the ubiquitin was labelled prior to (left panel) or after (right panel) incubation with lysate (some lysate proteins were also labelled in the latter case, but the labelling of these was diminished in the presence of ubiquitin). These reciprocal experiments showed that the appearance of the labelled high molecular mass material was specific to the inclusion of exogenous ubiquitin, and that the behaviour of ubiquitin closely mirrors that of the 205 proteins.
We were unable to stimulate ubiquitination of target proteins by the addition of purified ubiquitin to translation reactions. But it proved possible to produce a lysate that was severely restricted in its capacity to modify target proteins by removal of much of the free ubiquitin pool using membrane filters with a l0 kDa cutoff (centricon 10 units, Amicon). When lysate so depleted was incubated with target (BstXI) protein, modification was at a much reduced level compared to untreated lysate (Fig. 4b, compare lanes 2 and 3) . However, supplementation of the depleted lysate with purified ubiquitin (lane 4) resulted in some restoration of the modifying activity. Although it is not certain which other small components of the lysate are removed by this treatment, restoration of modifying activity specifically Products were separated on a 15% polyacrylamide SDS gel and visualized by autoradiography.
by purified u b i q u i t i n provides good evidence that the observed modification of the 205 proteins by reticulocyte lysate is due to ubiquitination.
Evidence for the involvement of the 26S A TP-dependent protease in the degradation of modified target proteins
As m e n t i o n e d previously, a characteristic feature of the ubiquitin-mediated A T P -d e p e n d e n t proteolytic system is the sensitivity of the multicatalytic protease to inhibition by y-S-ATP, while u b i q u i t i n a t i o n remains refractory to this agent. We investigated the effect of y-S-ATP u p o n the degradation of modified target proteins more closely. In Fig. 5(a) , where BstXI target protein was incubated with excess lysate for the times indicated, modification was seen to occur rapidly within the first 10 m i n (as shown by the a c c u m u l a t i o n of label at the top of the gel) and was essentially complete by 60 min. Thereafter, degradation of the high molecular mass material was seen to proceed during the further 2 h of incubation. In contrast, while it could be seen that in the presence of 7-S-ATP modification of the target was unaffected, degradation over the same period was significantly reduced, with a greater p r o p o r t i o n of material remaining at the top of the gel. A similar pattern of events was obtained when the AN Pvu target was used (Fig. 5b) . These data demonstrate clearly the A T P The behaviour of the 205 proteins is consistent with that established for the control E6-cyclin protein as demonstrated in parallel experiments (Fig. 6 ). Since ubiquitination of E6 requires association with a 100 k D a reticulocyte lysate protein (E6-AP) which is absent in wheatgerm extract (Scheffner et al., 1993) , unubiquitinated E6-cyclin can be synthesized in wheatgerm extract (lane 1) and subsequently ubiquitinated and degraded by the addition of reticulocyte lysate (lane 4).
In the presence of y-S-ATP, degradation is inhibited as shown by the stabilization of ubiquitinated protein at the top of the gel (lane 5).
Further characterization o f the C-terminal degron
Partial characterization o f the C-terminal degron was carried out in terms of its context specificity. Fig. 7 (a) shows the result of transferring the C-terminal region of 205 (downstream from the X m n I site at position 10184) containing the degradation signal to a normally stable heterologous protein, the influenza virus ( A / P R / 8 / 3 4 ) PB 1 protein (the primary structures of the proteins are shown in Fig. 7b ). The wild-type PB 1 protein was completely stable when incubated with excess lysate (Fig.  7a, compare lanes 1 and 2) whereas incubation of the PB1/205 translation product (lane 3) with excess lysate (lane 4) resulted in complete conversion to the high molecular mass forms. However, the rate of decay would appear to be low, as shown by the similar levels of material remaining (at the top of the gel) either in the absence or presence of y-S-ATP (compare lanes 4 and 5). Removal of the C-terminal half of the PBx protein resulted in a markedly less stable chimeric protein, as shown by comparing the high molecular mass material remaining in the absence or presence of inhibitor (compare lanes 9 and 10), whereas the control Nterminal portion of PB 1 (lane 6) remained relatively stable (lane 7). Thus the 205 C-terminal signal appears to be transplantable and to act independently of the Nterminal sequence which precedes it.
Together these data provide evidence that the observed instability of the 205 proteins is due to ubiquitin-targeted degradation and concur with the findings of Lawson et al. (1994) for a picornavirus 3C protease. We conclude, therefore, that two regions of the ORF la polyprotein encoded by pKT205 are potential targets for ubiquitinmediated ATP-dependent degradation.
Discussion
We have presented data which suggest that a region of the IBV ORF la polyprotein bears two degrons which result in ubiquitin modification of in vitro-expressed product(s) followed by degradation of the targeted protein(s) by an ATP-dependent protease present in reticulocyte lysate. This is the third reported example of a viral protein subject to turnover in this manner and involves a different virus class to the previously reported examples, in a picornavirus (Oberst et al., 1993) and an alphavirus (de Groot et al., 1991) . In addition, the identification of this process adds to the repertoire of regulatory mechanisms potentially used by coronaviruses.
The ubiquitin-mediated ATP-dependent proteolytic pathway is a major cellular non-lysosomal protein degradation system and is responsible for modulating the levels of many cellular proteins, either for the purposes of regulation or the removal of damaged or abnormal proteins (reviewed in Gottesman & Maurizi, 1992; Ciechanover & Schwartz, 1994) . The system comprises two processes, both of which display a requirement for ATP. The targeting of the protein for degradation involves modification by the covalent attachment of ubiquitin to acceptor lysine residues by certain ligase enzymes (reviewed in Hershko & Ciechanover, 1992) .
While ubiquitin modification may vary in degree and may play other roles in cellular regulation, it seems that multiubiquitin chains are required most frequently to target proteins for proteolysis (reviewed in Jentsch, 1992) . Degradation of the targeted protein is carried out by the 26S ATP-dependent protease, a complex of several types of subunits with a range of proteolytic activities (reviewed in Hershko & Ciechanover, 1992; Rechsteiner et al., 1993) . Despite the fact that the components of the two processes are becoming increasingly well characterized, the precise signals determining the metabolic stability of any given protein remain much less well understood. Several sequences have been found that contribute to the short half-life of some proteins, but no overall pattern has yet to emerge (reviewed in Ciechanover & Schwartz, 1994) . One exception is the N-end rule or N-degron (Bachmair et al., 1986; reviewed in Varshavsky, 1992) , which relates the stability of a protein to the identity of its N-terminal amino acid, which may be stabilizing or destabilizing. This is a two part degron in that a destabilizing Nterminal amino acid promotes the multiple ubiquitination of a nearby lysine residue. Although this pathway is thought to play only a minor physiological role, it has been found to be responsible for the rapid turnover of Sindbis virus polymerase (de Groot et al., 1991) . Metabolic instability is a common feature of many cellular regulatory proteins and this may also apply to viral non-structural proteins such as the proteases and polymerases of positive-strand viruses. This may become apparent as more information concerning the expression patterns of these proteins accumulates.
One of the degrons identified in the 205 sequence was mapped to the predicted 3C protease domain and is most likely located towards the N terminus of the mature protein, based upon the predicted cleavage release sites. The N-and C-terminal boundaries of the 205/BstXI protein are close to these cleavage sites and so this protein might be structurally similar to mature 3CLP. It is possible therefore that the instability observed is significant in terms of the virus life-cycle, although in the absence of cleavage data or in vivo expression data (the protein has yet to be identified in infected cells) it is not possible to determine fully the relevance of this finding to the control of coronavirus 3C expression and function. However, there is a close parallel between our observations and those of Lawson et al. (1994) concerning the low in vitro stability of EMCV 3C protease, which itself accords with the observed in vivo metabolic instability of several viral proteases in the 3C-like group (Oberst et al., 1993) . The coronavirus 3C domain may thus exhibit this characteristic feature of the 3C protease family as a conserved trait. Recent evidence in the case of HCV 229E 3C protease expression in vivo (Ziebuhr et al., 1995) may support this contention. Regulation of 3C protease activity through metabolic instability may be an important control process involved in coronavirus replication; this protease is likely to play a key role in the processing and maturation of ORF 1 proteins, possibly including downstream trans cleavages in the lb region (Liu et al., 1994) which contains the putative polymerase domain(s) (Gorbalenya et al., 1989) .
The potential function of the second degron identified towards the C terminus of the 205 translation product is not obvious at the present time; it lies within a region of ORF la with no postulated function. This degron is apparently context-independent in that its relative position within the region of the la protein expressed does not affect its activity. Indeed, this signal is transplantable from its native context such as to confer instability upon a normally stable heterologous protein (PB 0. This property has been reported previously for the Degl degradation signal located within the yeast MATa2 repressor and for the N terminus of the HPV-16 E6 protein (Chen et al., 1993; Crook & Vousden, 1994) . Such a degradation signal could prove potentially useful in destabilizing a protein of choice either in cis (as above) or in trans by analogy to the natural targeting of cellular p53 protein by the HPV-16 E6 protein (Crook & Vousden, 1994) , although subunit preference (specificity) in the degradation of multicomplex proteins has been observed (Hochstrasser & Varshavsky, 1990) . The property of a degron to function in a context-independent manner may be an important prerequisite for the control of differently processed versions of a polyprotein or to enable regulation of downstream functions whose effectors have yet to be processed from the polyprotein (possibly by 3C). It is of relevance to note here that Oberst et al. (1993) reported a hierarchical pattern of stability of different 3C-bearing polyprotein fragments. Thus, the two degrons identified here may both have significant impact upon the cellular levels of ORF 1 products.
Neither degron identified within the 205 protein appears to conform to the N-end rule. All the expressed products described here bear at least 4 amino acids at their N-termini that are derived from highly stable influenza virus proteins. According to the rules governing their removal (Flinta et al., 1986; Ciechanover & Schwartz, 1994) it is unlikely that the N-terminal methionine residues of these proteins would be removed to reveal the destabilizing aspartate residues which follow in each case. Moreover, involvement of the N-degron in IBV 3C turnover would not be expected if mature 3C is derived in the way predicted from the proposed cleavage sites (Gorbalenya et al., 1989) , since the N-terminal residue would be serine, which is stabilizing according to the N-end rule. Confirmation will await identification of 3C in vivo, analysis of its metabolic stability and verification of the authentic cleavage sites. Currently we are generating an antiserum against the 3C domain to aid in achieving these aims.
As yet there are no indications as to how the region of the la polyprotein surrounding 3C is processed. The apparent lack of auto-processivity of the 205 product in vitro is unexpected but may be related to the residual (possibly uncleavable) protein sequence upstream of the predicted N terminus of 3C. This condition has been found to abrogate the activity of a cloned protease of hepatitis C virus (D. Rowlands, personal communication). Alternatively, it is possible that additional sequences are required for activity which lie beyond the confines of the 205 clone. Efforts to define and characterize active forms of 3C and/or other regions of ORF 1 which process in vitro remain in progress.
